Phreesia, Inc. (NYSE:PHR) Given Average Recommendation of “Moderate Buy” by Analysts

Shares of Phreesia, Inc. (NYSE:PHR) have earned an average rating of “Moderate Buy” from the fourteen brokerages that are presently covering the firm, MarketBeat Ratings reports. Two analysts have rated the stock with a hold recommendation and twelve have given a buy recommendation to the company. The average 12 month price objective among brokerages that have covered the stock in the last year is $31.62.

A number of equities analysts have issued reports on PHR shares. DA Davidson reaffirmed a “neutral” rating and issued a $32.00 target price on shares of Phreesia in a report on Friday, March 15th. Truist Financial initiated coverage on Phreesia in a report on Monday, February 26th. They issued a “buy” rating and a $35.00 target price for the company. Royal Bank of Canada reiterated a “sector perform” rating and issued a $23.00 price target on shares of Phreesia in a research report on Thursday, March 21st. Raymond James reiterated an “outperform” rating and issued a $30.00 price target (up previously from $25.00) on shares of Phreesia in a research report on Friday, March 15th. Finally, Robert W. Baird upped their price target on Phreesia from $30.00 to $31.00 and gave the company an “outperform” rating in a research report on Monday, March 18th.

Phreesia Price Performance

Phreesia stock opened at $22.77 on Tuesday. The company has a debt-to-equity ratio of 0.02, a quick ratio of 1.78 and a current ratio of 1.78. Phreesia has a 52 week low of $12.05 and a 52 week high of $34.98. The stock has a market capitalization of $1.28 billion, a P/E ratio of -9.04 and a beta of 0.92. The stock has a fifty day moving average of $24.64 and a 200-day moving average of $21.20.

Phreesia (NYSE:PHR) last issued its earnings results on Thursday, March 14th. The company reported ($0.56) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.58) by $0.02. Phreesia had a negative return on equity of 53.33% and a negative net margin of 38.42%. The business had revenue of $95.00 million during the quarter, compared to analysts’ expectations of $93.52 million. During the same quarter in the prior year, the firm earned ($0.72) EPS. The business’s revenue for the quarter was up 24.0% compared to the same quarter last year. On average, sell-side analysts expect that Phreesia will post -1.48 earnings per share for the current fiscal year.

Insiders Place Their Bets

In other news, insider Janet Gunzburg sold 2,817 shares of the stock in a transaction that occurred on Tuesday, March 19th. The stock was sold at an average price of $23.27, for a total value of $65,551.59. Following the completion of the sale, the insider now directly owns 40,609 shares of the company’s stock, valued at $944,971.43. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. In other news, insider Janet Gunzburg sold 2,817 shares of the stock in a transaction that occurred on Tuesday, March 19th. The stock was sold at an average price of $23.27, for a total value of $65,551.59. Following the completion of the sale, the insider now directly owns 40,609 shares of the company’s stock, valued at $944,971.43. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, COO Evan Roberts sold 25,962 shares of the stock in a transaction that occurred on Thursday, March 21st. The stock was sold at an average price of $23.52, for a total value of $610,626.24. Following the completion of the sale, the chief operating officer now directly owns 728,570 shares of the company’s stock, valued at $17,135,966.40. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 73,516 shares of company stock worth $1,695,194. Corporate insiders own 5.80% of the company’s stock.

Institutional Trading of Phreesia

A number of institutional investors and hedge funds have recently modified their holdings of PHR. International Assets Investment Management LLC increased its position in shares of Phreesia by 1,987.3% during the fourth quarter. International Assets Investment Management LLC now owns 1,482 shares of the company’s stock valued at $34,000 after acquiring an additional 1,411 shares during the last quarter. Captrust Financial Advisors increased its position in shares of Phreesia by 154.6% during the second quarter. Captrust Financial Advisors now owns 1,426 shares of the company’s stock valued at $36,000 after acquiring an additional 866 shares during the last quarter. Acadian Asset Management LLC purchased a new stake in shares of Phreesia during the first quarter valued at approximately $43,000. State of Wyoming increased its position in shares of Phreesia by 34.6% during the second quarter. State of Wyoming now owns 1,918 shares of the company’s stock valued at $59,000 after acquiring an additional 493 shares during the last quarter. Finally, Tower Research Capital LLC TRC increased its position in shares of Phreesia by 85.4% during the third quarter. Tower Research Capital LLC TRC now owns 3,137 shares of the company’s stock valued at $80,000 after acquiring an additional 1,445 shares during the last quarter. 92.10% of the stock is owned by hedge funds and other institutional investors.

About Phreesia

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.